You're totally missing it; how can you not see it. Last year the results where not consolidated. So of course it looks like a huge increase this year because the 49.7 million of RXMD was not included within NXPL results last year. 🤦🏻♂️
Subtract the 24.9 mill of Pharmacy revenue from the 65.5 mill reported today and you end up with 40.6 mill of revenue attributed to NXPL operations, which is a mere 2.8 mill increase for NXPL products as a whole during 2024, 37.8 mill is what NXPL reported for year end 2023.
Make sense now? Am I missing something you see?
If today's numbers are so great why is the PPS dropping, how do you justify the sell activity?